Although GLP-1 receptor agonists (GLP-1RAs) were initially developed for the management of diabetes and weight loss, their therapeutic applications have since broadened considerably to encompass a range of cardiovascular, renal, and metabolic disorders [15,16,17]
proposed that iron-induced lipid peroxidation impaired -aminobutyric acid (GABA) release and uptake, leading to GABA inhibition as a possible neurochemical pathogenesis of iron-induced epilepsy (12)
Let's explore some essential tips to complement your treatment and improve your weight loss efforts: As you embark on your weight management journey with GLP-1 analogues, remember that incorporating practical tips and lifestyle changes can be instrumental in achieving your health goals
We asked a doctor to share everything you need to know about how Zepbound boosts weight loss, who should consider it and how the new KwikPen injectable works
Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the global burden of disease study 2015